As of March 2025 Revance Therapeutics has a market cap of £0.29 Billion. This makes Revance Therapeutics the world's 7256th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.